Company Filing History:
Years Active: 2015
Title: Innovations of Steve Bartz in RNA Interference
Introduction
Steve Bartz is an accomplished inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of RNA interference. His work focuses on the modulation of gene expression, which has important implications for the treatment of viral infections.
Latest Patents
Steve Bartz holds a patent for "RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)." This invention relates to compounds, compositions, and methods for studying, diagnosing, and treating diseases that respond to the modulation of HBV gene expression. The patent specifically involves double-stranded nucleic acid molecules, including small nucleic acid molecules such as siNA, siRNA, dsRNA, miRNA, and shRNA, which are capable of mediating RNA interference against HBV gene expression. He has 1 patent to his name.
Career Highlights
Steve Bartz is currently associated with Sirna Therapeutics, Inc., where he continues to advance his research in RNA interference. His innovative work has the potential to lead to new therapeutic strategies for combating hepatitis B virus infections.
Collaborations
Some of his notable coworkers include Duncan F Brown and Michael Robinson, who have collaborated with him on various projects related to RNA interference and gene expression modulation.
Conclusion
Steve Bartz's contributions to the field of biotechnology, particularly through his patent on RNA interference, highlight his role as a key innovator in the fight against viral infections. His work continues to pave the way for advancements in medical treatments.